US 11,058,677 · Application 14/650,955 · Granted Jul 13, 2021
US 11,058,677
Lfa-1 inhibitor formulations
Estimated expiration
December 18, 2033
7y 83d remaining
Earliest effective filing
Dec 18, 2013
+ 20 years
Dec 18, 2033
PTA +0d
Dec 18, 2033
No TD
—
Final
Dec 18, 2033
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.
Calculation details
Base term
- Filing date
- June 10, 2015
- Earliest effective filing
- December 18, 2013
- Issue date
- July 13, 2021
- PTA
- 0 days
- Base expiry (before PTA)
- December 18, 2033
December 18, 2013 + 20 years = December 18, 2033
- National stage entry of application PCTUS2013076041, filed Dec 18, 2013
- PRO61/758,147 — Provisional — not used for base term
- PRO61/739,609 — Provisional — not used for base term
- PRO61/739,609 — Provisional — not used for base term
- PRO61/758,147 — Provisional — not used for base term
Terminal disclaimers
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 14/650,955 · US 11,058,677
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 11,058,677: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US11058677Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.